ZyVersa Therapeutics, Inc. (ZVSA)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Aug. 5, 2025 | CORRESP | Neutral/Informational | Moderate | ZyVersa Therapeutics, Inc. has submitted a request for the acceleration of the effective date of their Registration Statement on Form S-1. The company aims for the statement to be… | Read Filing EDGAR |
| Aug. 1, 2025 | CORRESP | Neutral/Informational | Moderate | ZyVersa Therapeutics, Inc. has submitted a response to the SEC regarding comments on their Amendment No. 1 to Registration Statement on Form S-1. The SEC had raised concerns about… | Read Filing EDGAR |
| Jul. 30, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed ZyVersa Therapeutics, Inc.'s amended registration statement and has issued a comment regarding the trading status of the company's common stock. They require … | Read Filing EDGAR |